Literature DB >> 29749098

Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis.

Ricarda Hannen1, Jörg W Bartsch1.   

Abstract

Maintenance of chromosomal telomere length is a hallmark of cancer cells and a prerequisite for stemness. In 85-90% of all human cancers, telomere length maintenance is achieved by reactivation of telomerase, whereas in the remaining 10-15% cancers, alternative lengthening of telomeres (ALT) is observed. Reactivation of telomerase occurs by various mechanisms, one of which is accumulation of point mutations in the promoter region of the gene encoding the protein subunit hTERT. There are numerous studies linking either hTERT overexpression or the presence of hTERT mutations to an aggressive phenotype of several human cancers. Recent findings demonstrate that hTERT expression is not only associated with replicative immortality, but also with cancer cell motility and stem cell phenotype. However, the mechanisms by which hTERT affects cancer cell migration, invasion, and distant metastasis on the one hand, and stemness and resistance on the other hand, are still poorly understood. Within this review, we aim to provide an overview on the functional involvement of hTERT in these cellular processes, focusing on metastasis formation and maintenance of stemness in different human cancers.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  cancer; cancer stem cells; hTERT; metastasis; reverse transcriptase; telomerase; telomeres

Mesh:

Substances:

Year:  2018        PMID: 29749098     DOI: 10.1002/1873-3468.13084

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.

Authors:  Nathaniel J Robinson; Derek J Taylor; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2019-05-06

2.  Correlation of TERT and Stem Cell Markers in the Context of Human Breast Cancer.

Authors:  Umar Wazir; Mona M A W Orakzai; Tracey Amanda Martin; Wen G Jiang; Kefah Mokbel
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

3.  Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.

Authors:  Ravneet Chhabra; Stephanie Rockfield; Jennifer Guergues; Owen W Nadeau; Robert Hill; Stanley M Stevens; Meera Nanjundan
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

4.  Upregulation of h-TERT and Ki-67 in ectopic endometrium is associated with recurrence of endometriosis.

Authors:  Jie Luo; Zhimin Song; Tao Zhang; Ketan Chu; Jingyi Li; Jianhong Zhou; Jun Lin
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

5.  hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.

Authors:  Pablo Moreno-Acosta; MÓnica Molano; Nicolas Morales; Jinneth Acosta; Cristian GonzÁlez-Prieto; Diana Mayorga; Lina Buitrago; Oscar Gamboa; Juan Carlos MejÍa; July Castro; Alfredo Romero-Rojas; Sophie Espenel; Gerald L Murray; Suzanne M Garland; Alexis Vallard; Nicolas MagnÉ
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 6.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.

Authors:  Alexander Kabakov; Anna Yakimova; Olga Matchuk
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

7.  NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.

Authors:  Vilde Drageset Haakensen; Anna K Nowak; Espen Basmo Ellingsen; Saima Jamil Farooqi; Maria Moksnes Bjaanæs; Henrik Horndalsveen; Tine Mcculloch; Oscar Grundberg; Susana M Cedres; Åslaug Helland
Journal:  J Transl Med       Date:  2021-05-31       Impact factor: 5.531

8.  RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors.

Authors:  Wei-Lien Wang; Nalan Gokgoz; Bana Samman; Irene L Andrulis; Jay S Wunder; Elizabeth G Demicco
Journal:  Mod Pathol       Date:  2020-10-02       Impact factor: 7.842

9.  hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression.

Authors:  Chunli Gong; Huan Yang; Sumin Wang; Jiao Liu; Zhibin Li; Yiyang Hu; Yang Chen; Yu Huang; Qiang Luo; Yuyun Wu; En Liu; Yufeng Xiao
Journal:  Front Cell Dev Biol       Date:  2021-05-17

10.  Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Authors:  Jihane Boustani; Elodie Lauret Marie Joseph; Etienne Martin; Salim Benhmida; Benoit Lecoester; Florent Tochet; Céline Mirjolet; Cédric Chevalier; David Thibouw; Noémie Vulquin; Stéphanie Servagi; Xushan Sun; Olivier Adotévi
Journal:  BMC Immunol       Date:  2021-06-18       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.